Trial intelligence / Profile preview

Liposomal Bupivacaine in Total Knee Arthroplasty

NCT02426164Phase 4Withdrawn

Sponsor
Miller Orthopedic Specialists
Start
Jun 2015
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Miller Orthopedic Specialists. Planned start Jun 2015; status: withdrawn.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02426164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02426164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call